Related Experiment Videos
Postoperative Inflammatory Complications Do Not Increase the Risk of Subsequent Primary Skin Cancer
Madelyn Schmidt1, Travis S Dowdle2, Richard F Wagner2
1School of Medicine, University of Texas Medical Branch, Galveston, TX.
Objective:
Although there is an established risk for subsequent nonmelanoma skin cancer (NMSC) development at sites unrelated to the initial cancer, it is unknown whether postoperative inflammatory complications (IC) augment this risk after Mohs micrographic surgery (MMS) or excisions. This study aims to evaluate the 3-year risk of NMSC in patients with post-surgical IC.
Methods:
Using the TriNetX Research Network, patients were identified focusing on patients who experienced IC within 1 month of MMS or excision for basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and squamous cell carcinoma in situ (SCCIS). The calculated hazard ratios (HRs) and absolute risk differences (ARDs) were compared with the previously reported 3-year risks of subsequent NMSC (44% for BCC and 18% for SCC/SCCIS).
Results:
The hazard ratio for SCC/SCCIS in patients with postoperative IC was statistically significant (HR: 1.08, 95% CI: [1.04, 1.12]; ARD: 2.43%, 95% CI: [1.23, 3.65]) but did not exceed the 18% 3-year risk benchmark and was not considered clinically significant. Inflammatory complications were protective against BCC development (HR: 0.93, 95% CI: [0.90, 0.97]; ARD: -1.68%, 95% CI: [-2.87, -0.51]).
Conclusions:
These findings suggest postoperative ICs do not increase the 3-year risk of NMSC development.
Insights
Postoperative inflammatory complications (IC) after skin cancer surgery do not increase the risk of developing new nonmelanoma skin cancers (NMSC). While a slight increase in squamous cell carcinoma risk was observed, it was not clinically significant and did not exceed benchmarks.
Area of Science:
- Dermatology
- Oncology
- Surgical Pathology
Background:
- Subsequent nonmelanoma skin cancer (NMSC) can develop at new sites after initial treatment.
- The impact of postoperative inflammatory complications (IC) on this subsequent risk is not well understood, particularly after Mohs micrographic surgery (MMS) or excisions.
Purpose of the Study:
- To evaluate the 3-year risk of subsequent NMSC in patients who experienced postoperative IC.
- To determine if IC influences the development of new basal cell carcinoma (BCC) or squamous cell carcinoma (SCC/SCCIS).
Main Methods:
- Utilized the TriNetX Research Network to identify patients with IC within one month of MMS or excision for BCC, SCC, or SCCIS.
- Calculated hazard ratios (HRs) and absolute risk differences (ARDs) for subsequent NMSC.
- Compared calculated risks against established 3-year benchmarks (44% for BCC, 18% for SCC/SCCIS).
Main Results:
- A statistically significant but not clinically significant increase in SCC/SCCIS risk was observed in patients with IC (HR: 1.08, ARD: 2.43%).
- This observed risk for SCC/SCCIS did not surpass the 18% benchmark.
- Interestingly, IC appeared protective against BCC development (HR: 0.93, ARD: -1.68%).
Conclusions:
- Postoperative inflammatory complications do not appear to elevate the 3-year risk of developing subsequent NMSC.
- The findings suggest that ICs may not be a significant risk factor for future NMSC development.
Related Concept Videos
Healing II: Complications
Peripheral Artery Disease V: Postoperative Nursing Management
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...